TD Asset Management
NVO

TD Asset Management’s Novo Nordisk NVO Stock Holding History

TD Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88M Buy
122,568
+21,990
+22% +$945K 0.01% 779
2026
Q1 		$3.7M Sell
100,578
-297,830
-75% -$14.1M ﹤0.01% 845
2025
Q4 		$20.3M Buy
+398,408
New +$20.4M 0.02% 512
2025
Q1 		– Sell
-598,638
Closed -$51.5M – 1252
2024
Q4 		$51.5M Sell
598,638
-421,759
-41% -$45.6M 0.05% 312
2024
Q3 		$123M Sell
1,020,397
-41,194
-4% -$5.49M 0.11% 174
2024
Q2 		$152M Sell
1,061,591
-12,431
-1% -$1.65M 0.14% 148
2024
Q1 		$138M Buy
1,074,022
+105,523
+11% +$12.6M 0.13% 162
2023
Q4 		$100M Buy
968,499
+44,150
+5% +$4.37M 0.1% 182
2023
Q3 		$84.1M Buy
924,349
+305,371
+49% +$26.9M 0.1% 164
2023
Q2 		$50.1M Buy
618,978
+302,838
+96% +$24.7M 0.06% 258
2023
Q1 		$25.2M Buy
+316,140
New +$22.4M 0.03% 401
2020
Q2 		– Sell
-235,842
Closed -$7.1M – 1396
2020
Q1 		$7.1M Buy
235,842
+43,292
+22% +$1.29M 0.01% 555
2019
Q4 		$5.57M Buy
192,550
+7,328
+4% +$203K 0.01% 691
2019
Q3 		$4.79M Buy
185,222
+12,506
+7% +$316K 0.01% 693
2019
Q2 		$4.41M Buy
172,716
+11,262
+7% +$278K 0.01% 712
2019
Q1 		$4.22M Buy
161,454
+12,070
+8% +$297K 0.01% 736
2018
Q4 		$3.44M Sell
149,384
-22,910
-13% -$509K 0.01% 772
2018
Q3 		$4.06M Buy
172,294
+17,992
+12% +$439K 0.01% 801
2018
Q2 		$3.56M Sell
154,302
-5,344
-3% -$127K 0.01% 790
2018
Q1 		$3.93M Buy
159,646
+9,116
+6% +$239K 0.01% 730
2017
Q4 		$4.04M Buy
150,530
+16,034
+12% +$408K 0.01% 727
2017
Q3 		$3.24M Buy
134,496
+6,156
+5% +$139K ﹤0.01% 763
2017
Q2 		$2.75M Buy
128,340
+42,314
+49% +$854K ﹤0.01% 810
2017
Q1 		$1.47M Buy
86,026
+13,104
+18% +$228K ﹤0.01% 947
2016
Q4 		$1.31M Buy
72,922
+1,264
+2% +$22.9K ﹤0.01% 958
2016
Q3 		$1.49M Sell
71,658
-5,946
-8% -$147K ﹤0.01% 929
2016
Q2 		$2.09M Sell
77,604
-1,024
-1% -$28.1K ﹤0.01% 851
2016
Q1 		$2.13M Sell
78,628
-22,198
-22% -$595K ﹤0.01% 834
2015
Q4 		$2.93M Sell
100,826
-4,706
-4% -$130K 0.01% 773
2015
Q3 		$2.86M Sell
105,532
-17,112
-14% -$484K 0.01% 761
2015
Q2 		$3.43M Buy
122,644
+2,754
+2% +$77.4K 0.01% 779
2015
Q1 		$2.69M Sell
119,890
-117,046
-49% -$2.7M ﹤0.01% 791
2014
Q4 		$5.01M Buy
236,936
+112,218
+90% +$2.51M 0.01% 662
2014
Q3 		$2.97M Buy
124,718
+82,926
+198% +$1.91M 0.01% 759
2014
Q2 		$965K Sell
41,792
-8,040
-16% -$178K ﹤0.01% 905
2014
Q1 		$1.14M Sell
49,832
-150,438
-75% -$3.21M ﹤0.01% 888
2013
Q4 		$3.7M Buy
200,270
+3,930
+2% +$68.5K 0.01% 712
2013
Q3 		$3.32M Sell
196,340
-15,390
-7% -$259K 0.01% 713
2013
Q2 		$3.28M Buy
+211,730
New +$3.52M 0.01% 677

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TD Asset Management's NVO Position: Q2 2026 in Review

TD Asset Management increased its Novo Nordisk (NVO) stake by 22% in Q2 2026, buying an estimated $945K and bringing the position to 122,568 shares worth $5.88M. The position accounts for 0.01% of the portfolio, ranked #779.

TD Asset Management first reported a position in NVO in Q2 2013 and has held it in 39 quarters since. The position peaked at $152M in Q2 2024. 1,138 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • TD Asset Management held 122,568 shares of Novo Nordisk worth $5.88M as of Q2 2026.
  • TD Asset Management bought 21,990 Novo Nordisk shares in Q2 2026, an estimated $945K.
  • Novo Nordisk made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #779 holding.
  • TD Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 39 quarters since.
  • TD Asset Management's Novo Nordisk position peaked at $152M in Q2 2024.
  • 1,138 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.